Clinical Trial Update: The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)

View source ↗

Summary

This clinical trial evaluated the diagnostic and prognostic utility of procalcitonin for ventilator-associated pneumonia. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Ventilator Associated Pneumonia | Status: TERMINATED